Skip to content

Clinical trials

Phase 2 Bronchiolitis Obliterans Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Phase: Phase 2 Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20071
20112
20121
20131
20152
20163
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Terminated3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Incyte Corporation2
Boston Scientific Corporation1
Celgene1
ElectroCore INC1
Genzyme, a Sanofi Company1
Gilead Sciences1
Mundipharma Research GmbH & Co KG1
Sanofi1
Syndax Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome16
Leukemia4
Chronic Urticaria2
Cluster Headache2
Graft vs Host Disease2
Leukemia, Lymphocytic, Chronic, B-Cell2
Leukemia, Myeloid, Acute2
Myelodysplastic Syndromes2
Pain2
Urticaria2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.